Honeywell International, Inc.
HON
$233.55
+1.82%
Honeywell International Inc. is a global industrial conglomerate operating across four key segments: Aerospace Technologies, Industrial Automation, Energy and Sustainability Solutions, and Building Automation. The company is a market leader known for its massive installed base of equipment and a significant recurring revenue stream from aftermarket services, which drives stability. The current investor narrative is dominated by the strategic portfolio transformation, specifically the planned spin-off of its Aerospace unit into a separate publicly traded entity (HONA), a move aimed at unlocking shareholder value and allowing both companies to focus on distinct growth markets. Recent headlines, including a major $500 million defense contract and the formal filing for the aerospace separation, underscore the company's pivotal restructuring efforts and its positioning within the robust aerospace and defense sector.…
HON
Honeywell International, Inc.
$233.55
Related headlines
Investment Opinion: Should I buy HON Today?
Rating: Hold. The core thesis is that Honeywell is a high-quality industrial undergoing a pivotal transformation, but its premium valuation and near-term revenue softness warrant a cautious stance until post-spin-off execution is demonstrated.
Supporting this view, the stock trades at a forward PE of 20.36x, a 23% discount to its trailing multiple, reflecting expected earnings growth but still at a premium to the sector. Analyst targets offer compelling +21.5% upside to $283.74, yet this is predicated on a successful spin-off and growth re-acceleration. The company's financial strength is undeniable, with an exceptional ROE of 30.63% and robust FCF of $5.39B, but Q4 revenue declined -3.28% YoY, creating a growth-over-valuation mismatch.
The thesis would upgrade to a Buy if the forward PE compresses below 19x (offering a larger margin of safety) or if post-spin-off quarterly reports show clear revenue re-acceleration above 5% YoY. It would downgrade to Sell if revenue growth turns negative for two consecutive quarters or if the spin-off process encounters significant delays or cost overruns. Based on the current data, the stock appears fairly valued relative to its own history but slightly overvalued relative to industrial peers, demanding perfect execution to justify its price.
Sign up to view all
HON 12-Month Price Forecast
The outlook for Honeywell is a story of high-quality fundamentals meeting a pivotal, risky transformation. The base case (55% probability) of a successful spin-off and stable execution leading to price targets in the $277-$284 range is most likely. However, confidence is tempered by the recent revenue deceleration and the stock's premium valuation, which leaves little room for error. The stance would upgrade to bullish on confirmation of revenue re-acceleration in the next two quarters or a successful spin-off launch. It would turn bearish if revenue declines accelerate or if significant spin-off complications emerge.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Honeywell International, Inc.'s 12-month outlook, with a consensus price target around $303.62 and implied upside of +30.0% versus the current price.
Average Target
$303.62
12 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
12
covering this stock
Price Range
$187 - $304
Analyst target range
Honeywell is covered by 12 analysts, indicating substantial institutional interest. The consensus sentiment leans bullish, with recent actions including upgrades to 'Outperform' (Wolfe Research) and maintained 'Overweight' or 'Buy' ratings from major firms like Barclays, Citigroup, and JP Morgan. The average target price implied by the estimated EPS and forward PE is $283.74 (20.36x forward PE * $13.93 estimated EPS), which represents a significant +21.5% upside from the current price of $233.55. The target range, derived from EPS estimates, spans from a low of $277.20 (based on the low EPS estimate of $13.61) to a high of $288.50 (based on the high EPS estimate of $14.17), implying a potential upside range of +18.7% to +23.5%. The high target likely assumes successful execution of the aerospace spin-off, multiple expansion, and a re-acceleration of growth, while the low target may factor in risks like integration challenges, macroeconomic headwinds, or further revenue softness. The relatively tight spread between the high and low targets suggests a reasonable degree of analyst consensus on the company's near-term earnings power.
Bulls vs Bears: HON Investment Factors
The evidence for Honeywell presents a balanced but slightly bullish tilt, driven by strong analyst conviction, exceptional capital efficiency, and a clear strategic catalyst in the aerospace spin-off. However, significant bearish pressures exist from recent revenue deceleration and a premium valuation that demands flawless execution. The single most important tension in the investment debate is whether the anticipated value creation from the spin-off and a return to growth can justify and sustain the stock's premium multiple, or if the current revenue softness signals a more fundamental challenge that could lead to valuation compression.
Bullish
- Strong Analyst Upside & Consensus: The average analyst target price of $283.74 implies a +21.5% upside from the current price of $233.55, based on a forward PE of 20.36x and estimated EPS of $13.93. The bullish consensus is reinforced by recent upgrades, including Wolfe Research to 'Outperform'.
- Exceptional Capital Efficiency: Honeywell's Return on Equity (ROE) of 30.63% is exceptionally high, indicating superior efficiency in deploying shareholder capital. This is supported by a robust trailing free cash flow of $5.39 billion, which funds dividends, buybacks, and strategic initiatives.
- Strategic Value Unlock via Spin-off: The planned spin-off of the Aerospace unit (HONA) is a major catalyst aimed at unlocking shareholder value by creating two focused companies. This is bolstered by recent news of a $500 million defense contract, solidifying the unit's position in a robust sector.
- Healthy Profitability & Margins: Despite recent revenue softness, the company maintains strong profitability with a trailing net margin of 12.63% and an operating margin of 17.54%. The Q4 gross margin of 35.56% is healthy for an industrial conglomerate.
Bearish
- Revenue Deceleration & Softness: Q4 2025 revenue of $9.758 billion declined -3.28% year-over-year, marking a sequential deceleration from Q2 and Q3. This near-term growth slowdown raises questions about the company's top-line momentum amidst its strategic transformation.
- Premium Valuation vs. Industrials: Honeywell's trailing PE of 26.36x trades at a premium to typical industrial conglomerates (often in the low-20s). This premium valuation leaves the stock vulnerable to compression if growth expectations are not met post-spin-off.
- Recent Relative Underperformance: The stock has underperformed the market recently, gaining only +1.58% over the past month versus the SPY's +7.36%, resulting in a negative 1-month relative strength of -5.78. This suggests the strong uptrend may be pausing or consolidating.
- Elevated Debt Load: The company's debt-to-equity ratio of 2.24 is elevated, which is a financial risk factor, though it is manageable given the strong free cash flow generation and current ratio of 1.32.
HON Technical Analysis
Honeywell's stock is in a strong, sustained uptrend, evidenced by a robust 1-year price change of +26.04%. As of the latest close of $233.55, the stock is trading near the top of its 52-week range, approximately 94% of the distance from its 52-week low of $181.07 to its high of $248.18, indicating significant positive momentum but also potential vulnerability to a pullback from overbought conditions. Recent short-term momentum, however, shows signs of cooling; the stock gained only +1.58% over the past month, significantly lagging the SPY's +7.36% return, and is up +6.45% over the last three months. This divergence suggests the stock may be consolidating or experiencing a temporary pause after its strong run, with a negative 1-month relative strength of -5.78 highlighting this recent underperformance. The stock's beta of 0.915 indicates it is slightly less volatile than the broader market, which is typical for a large-cap industrial. Key technical levels to watch are the 52-week high of $248.18 as immediate resistance and the 52-week low of $181.07 as major support; a decisive breakout above $248.18 could signal a resumption of the primary uptrend, while a break below the recent consolidation range near $220 could indicate a deeper correction.
Beta
0.92
0.92x market volatility
Max Drawdown
-17.0%
Largest decline past year
52-Week Range
$181-$248
Price range past year
Annual Return
+26.0%
Cumulative gain past year
| Period | HON Return | S&P 500 |
|---|---|---|
| 1m | +1.6% | +9.5% |
| 3m | +6.5% | +2.7% |
| 6m | +22.1% | +5.8% |
| 1y | +26.0% | +34.9% |
| ytd | +19.2% | +4.1% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
HON Fundamental Analysis
Honeywell's revenue trajectory shows signs of softness, with the most recent Q4 2025 revenue of $9.758 billion representing a -3.28% year-over-year decline. This follows a pattern of sequential revenue decreases from Q2 ($10.353B) and Q3 ($10.408B), indicating a near-term growth deceleration. However, the company maintains strong profitability, with a Q4 net income of $295 million and a trailing twelve-month net margin of 12.63%. Gross margin in Q4 was 35.56%, which is slightly below the full-year average implied by the valuation gross margin of 36.93%, suggesting some quarterly pressure, but the operating margin of 17.54% remains healthy for an industrial conglomerate. The balance sheet and cash flow position is robust, with a trailing free cash flow of $5.393 billion providing ample liquidity for dividends, buybacks, and strategic initiatives. The debt-to-equity ratio of 2.24 is elevated but manageable for a capital-intensive industrial, supported by a strong current ratio of 1.32. The company's return on equity of 30.63% is exceptionally high, indicating efficient use of shareholder capital, and the substantial free cash flow generation underpins its financial flexibility and ability to fund its strategic transformation internally.
Quarterly Revenue
$9.8B
2025-12
Revenue YoY Growth
-0.03%
YoY Comparison
Gross Margin
+0.35%
Latest Quarter
Free Cash Flow
$5.4B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is HON Overvalued?
Given Honeywell's consistent profitability, the primary valuation metric is the Price-to-Earnings (PE) ratio. The stock trades at a trailing PE of 26.36x and a forward PE of 20.36x based on estimated EPS. The forward PE being approximately 23% lower than the trailing multiple reflects the market's expectation of earnings growth in the coming year. Compared to the broader industrials sector, Honeywell's trailing PE of 26.36x is at a premium; for context, a typical industrial conglomerate might trade closer to the low-20s, suggesting the market is pricing in Honeywell's premium positioning, high ROE, and strategic initiatives. Historically, the stock's own PE ratio has fluctuated significantly, from lows near 18x to highs above 100x in recent quarters (the Q4 2025 figure of 105x appears to be an anomaly due to a low quarterly EPS). The current trailing multiple of 26.36x sits comfortably within the middle of its longer-term historical range, suggesting the stock is neither excessively cheap nor expensive based on its own history, balancing growth expectations against its recent revenue softness.
PE
26.4x
Latest Quarter
vs. Historical
Low-End
5-Year PE Range 18x~105x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
17.9x
Enterprise Value Multiple
Investment Risk Disclosure
Financially, Honeywell's primary risk is its elevated debt-to-equity ratio of 2.24, which, while supported by strong free cash flow ($5.39B TTM), increases interest expense sensitivity in a rising rate environment. Operationally, the sequential revenue decline from Q2 ($10.35B) to Q4 ($9.76B), culminating in a -3.28% YoY drop, signals growth deceleration that could pressure earnings if it persists. The company's valuation, at a trailing PE of 26.36x—a premium to industrial peers—creates a high bar for performance, making the stock vulnerable to multiple compression if execution falters.
Market and competitive risks center on valuation and the spin-off. Trading at 94% of its 52-week high-to-low range, the stock is technically extended and susceptible to a pullback, especially given its recent 1-month underperformance vs. the SPY (-5.78% relative strength). The planned aerospace separation, while a catalyst, introduces uncertainty and the risk that the sum-of-the-parts valuation does not meet market expectations. Furthermore, as a conglomerate, the remaining 'New Honeywell' faces the challenge of proving its growth narrative in automation and sustainability against more focused competitors.
The worst-case scenario involves a failure to reignite revenue growth combined with execution missteps in the spin-off process, leading to a loss of investor confidence. This could trigger analyst downgrades and a derating of the PE multiple towards the industrial sector average. A realistic downside could see the stock retreat to its 52-week low of $181.07, which would represent a -22.5% decline from the current price of $233.55. A more severe bear case, incorporating broader market stress, could see a drawdown approaching the stock's recent max drawdown of -16.96%.
FAQ
The key risks are, in order of severity: 1) Execution Risk: Complications or delays in the planned aerospace spin-off could destroy expected shareholder value. 2) Growth Risk: The recent revenue deceleration (Q4 -3.28% YoY) could persist, undermining the growth narrative and justifying a lower multiple. 3) Valuation Risk: The stock's premium trailing PE of 26.36x makes it vulnerable to compression if growth stalls or market sentiment sours. 4) Financial Risk: An elevated debt-to-equity ratio of 2.24, though manageable, increases interest expense sensitivity.
The 12-month forecast centers on three scenarios. The base case (55% probability) sees the stock reaching the analyst average target range of $277-$284, driven by a successful spin-off and stable execution. The bull case (30% probability) could push the stock above $288 if the spin-off unlocks major value and growth re-accelerates sharply. The bear case (15% probability) could see the stock fall towards its 52-week low of $181 if execution fails and revenue declines worsen. The most likely outcome is the base case, contingent on the spin-off proceeding smoothly and revenue growth stabilizing.
HON appears fairly valued relative to its own historical range but slightly overvalued compared to the broader industrial sector. Its trailing PE of 26.36x is at a premium to typical industrial conglomerates, which often trade in the low-20s. However, its forward PE of 20.36x, based on estimated EPS growth, is more reasonable. The valuation implies the market is paying for Honeywell's premium positioning, high profitability, and the anticipated value creation from the spin-off. It is not deeply undervalued, and any investment thesis relies on these expectations being met.
HON is a good buy for investors with a medium-term horizon who believe in the value-unlocking potential of its aerospace spin-off and can tolerate the near-term revenue softness. The average analyst target of $283.74 offers a compelling +21.5% upside, and the company's exceptional ROE (30.63%) and strong FCF ($5.39B) provide a quality foundation. However, it is not a low-risk buy; the premium valuation (26.36x trailing PE) and recent revenue decline (-3.28% YoY) mean it is best suited for those confident in management's execution of the strategic transformation.
HON is best suited for a medium- to long-term investment horizon of 2-3 years. The stock's beta of 0.915 indicates lower volatility, aligning with a buy-and-hold strategy. The core investment thesis revolves around the multi-year value creation from the portfolio transformation, which will take time to fully materialize and be reflected in the financials. It is less ideal for short-term trading due to its recent underperformance vs. the market and the binary, event-driven nature of the upcoming spin-off, which could cause significant volatility around the separation date.
